Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 292

1.

Developing and Validating Risk Assessment Models of Clinical Outcomes in Modern Oncology.

Halabi S, Li C, Luo S.

JCO Precis Oncol. 2019;3. doi: 10.1200/PO.19.00068. Epub 2019 Oct 24.

2.

Erratum: Author Correction: Human-machine partnership with artificial intelligence for chest radiograph diagnosis.

Patel BN, Rosenberg L, Willcox G, Baltaxe D, Lyons M, Irvin J, Rajpurkar P, Amrhein T, Gupta R, Halabi S, Langlotz C, Lo E, Mammarappallil J, Mariano AJ, Riley G, Seekins J, Shen L, Zucker E, Lungren MP.

NPJ Digit Med. 2019 Dec 10;2:129. doi: 10.1038/s41746-019-0198-6. eCollection 2019.

3.

Improved Reporting in Abstracts When Uncertainty Is Inevitable.

Halabi S, Day S.

JAMA Netw Open. 2019 Dec 2;2(12):e1917543. doi: 10.1001/jamanetworkopen.2019.17543. No abstract available.

PMID:
31834388
4.

Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs.

Balogh EP, Bindman AB, Eckhardt SG, Halabi S, Harvey RD, Jaiyesimi I, Miksad R, Moses HL, Nass SJ, Schilsky RL, Sun S, Torrente JM, Warren KE.

Oncologist. 2019 Dec 4. pii: theoncologist.2019-0698. doi: 10.1634/theoncologist.2019-0698. [Epub ahead of print]

5.

Human-machine partnership with artificial intelligence for chest radiograph diagnosis.

Patel BN, Rosenberg L, Willcox G, Baltaxe D, Lyons M, Irvin J, Rajpurkar P, Amrhein T, Gupta R, Halabi S, Langlotz C, Lo E, Mammarappallil J, Mariano AJ, Riley G, Seekins J, Shen L, Zucker E, Lungren M.

NPJ Digit Med. 2019 Nov 18;2:111. doi: 10.1038/s41746-019-0189-7. eCollection 2019. Erratum in: NPJ Digit Med. 2019 Dec 10;2:129.

6.

In fetuses with congenital lung masses, decreased ventricular and atrioventricular valve dimensions are associated with lesion size and clinical outcome.

Mardy C, Blumenfeld YJ, Arunamata AA, Girsen AI, Sylvester KG, Halabi S, Rubesova E, Hintz SR, Tacy TA, Maskatia SA.

Prenat Diagn. 2019 Nov 19. doi: 10.1002/pd.5612. [Epub ahead of print]

PMID:
31742724
7.

Obstetric and neonatal outcomes in pregnancies complicated by fetal lung masses: does final histology matter?

Anderson JN, Girsen AI, Hintz SR, El-Sayed YY, Davis AS, Barth RA, Halabi S, Hazard FK, Sylvester KG, Bruzoni M, Blumenfeld YJ.

J Matern Fetal Neonatal Med. 2019 Nov 13:1-7. doi: 10.1080/14767058.2019.1689559. [Epub ahead of print]

PMID:
31722592
8.

Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.

Gupta S, Hovelson DH, Kemeny G, Halabi S, Foo WC, Anand M, Somarelli JA, Tomlins SA, Antonarakis ES, Luo J, Dittamore RV, George DJ, Rothwell C, Nanus DM, Armstrong AJ, Gregory SG.

Genes Chromosomes Cancer. 2019 Nov 9. doi: 10.1002/gcc.22824. [Epub ahead of print]

PMID:
31705765
9.

Children Immunization App (CImA) Among Syrian Refugees in Zaatari Camp, Jordan: Protocol for a Cluster Randomized Controlled Pilot Trial Intervention Study.

Khader YS, Laflamme L, Schmid D, El-Halabi S, Abu Khdair M, Sengoelge M, Atkins S, Tahtamouni M, Derrough T, El-Khatib Z.

JMIR Res Protoc. 2019 Oct 7;8(10):e13557. doi: 10.2196/13557.

10.

Giant aggressive forehead tumor: A 15-year follow-up.

Challita R, Halabi S.

Clin Pract. 2019 Aug 2;9(3):1172. doi: 10.4081/cp.2019.1172. eCollection 2019 Aug 2.

11.

Phosphorylation of the multifunctional signal transducer B-cell adaptor protein (BCAP) promotes recruitment of multiple SH2/SH3 proteins including GRB2.

Lauenstein JU, Udgata A, Bartram A, De Sutter D, Fisher DI, Halabi S, Eyckerman S, Gay NJ.

J Biol Chem. 2019 Dec 27;294(52):19852-19861. doi: 10.1074/jbc.RA119.009931. Epub 2019 Sep 16.

12.

Phase 2 clinical trial of TORC1 inhibition with everolimus in men with metastatic castration-resistant prostate cancer.

George DJ, Halabi S, Healy P, Jonasch D, Anand M, Rasmussen J, Wood SY, Spritzer C, Madden JF, Armstrong AJ.

Urol Oncol. 2019 Sep 12. pii: S1078-1439(19)30333-3. doi: 10.1016/j.urolonc.2019.08.015. [Epub ahead of print]

PMID:
31522863
13.

Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration-resistant prostate cancer.

George DJ, Halabi S, Healy P, Barak I, Winters C, Anand M, Wilder R, Klein M, Martinez E, Nixon AB, Harrison MR, Szmulewitz R, Armstrong AJ.

Prostate. 2019 Nov;79(15):1752-1761. doi: 10.1002/pros.23899. Epub 2019 Sep 9.

PMID:
31497882
14.

Radial Versus Femoral Approach in Women Undergoing Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.

Al Halabi S, Burke L, Hussain F, Lopez J, Mathew V, Bernat I, Shroff A.

J Invasive Cardiol. 2019 Nov;31(11):335-340. Epub 2019 Aug 15.

15.

Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial.

George DJ, Hessel C, Halabi S, Michaelson MD, Hahn O, Walsh M, Picus J, Small EJ, Dakhil S, Feldman DR, Mangeshkar M, Scheffold C, Morris MJ, Choueiri TK.

Oncologist. 2019 Nov;24(11):1497-1501. doi: 10.1634/theoncologist.2019-0316. Epub 2019 Aug 9.

16.

A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses.

Xie W, Halabi S, Tierney JF, Sydes MR, Collette L, Dignam JJ, Buyse M, Sweeney CJ, Regan MM.

JNCI Cancer Spectr. 2019 Feb 6;3(1):pkz002. doi: 10.1093/jncics/pkz002. eCollection 2019 Mar. Review.

17.

Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana.

Makhema J, Wirth KE, Pretorius Holme M, Gaolathe T, Mmalane M, Kadima E, Chakalisa U, Bennett K, Leidner J, Manyake K, Mbikiwa AM, Simon SV, Letlhogile R, Mukokomani K, van Widenfelt E, Moyo S, Lebelonyane R, Alwano MG, Powis KM, Dryden-Peterson SL, Kgathi C, Novitsky V, Moore J, Bachanas P, Abrams W, Block L, El-Halabi S, Marukutira T, Mills LA, Sexton C, Raizes E, Gaseitsiwe S, Bussmann H, Okui L, John O, Shapiro RL, Pals S, Michael H, Roland M, DeGruttola V, Lei Q, Wang R, Tchetgen Tchetgen E, Essex M, Lockman S.

N Engl J Med. 2019 Jul 18;381(3):230-242. doi: 10.1056/NEJMoa1812281.

18.

Reply to L. Dirix, B. De Laere et al, and A. Sharp et al.

Armstrong AJ, Halabi S, Luo J, Nanus DM, Scher HI, Antonarakis ES, George DJ.

J Clin Oncol. 2019 Aug 20;37(24):2184-2186. doi: 10.1200/JCO.19.01230. Epub 2019 Jul 2. No abstract available.

PMID:
31265357
19.

Deep Learning-Assisted Diagnosis of Cerebral Aneurysms Using the HeadXNet Model.

Park A, Chute C, Rajpurkar P, Lou J, Ball RL, Shpanskaya K, Jabarkheel R, Kim LH, McKenna E, Tseng J, Ni J, Wishah F, Wittber F, Hong DS, Wilson TJ, Halabi S, Basu S, Patel BN, Lungren MP, Ng AY, Yeom KW.

JAMA Netw Open. 2019 Jun 5;2(6):e195600. doi: 10.1001/jamanetworkopen.2019.5600.

20.

The evolution and understanding of skeletal complication endpoints in clinical trials of tumors with metastasis to the bone.

Hussain A, Lee RJ, Graff JN, Halabi S.

Crit Rev Oncol Hematol. 2019 Jul;139:108-116. doi: 10.1016/j.critrevonc.2019.04.020. Epub 2019 Apr 30. Review.

21.

Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer.

Armstrong AJ, Gupta S, Healy P, Kemeny G, Leith B, Zalutsky MR, Spritzer C, Davies C, Rothwell C, Ware K, Somarelli JA, Wood K, Ribar T, Giannakakou P, Zhang J, Gerber D, Anand M, Foo WC, Halabi S, Gregory SG, George DJ.

PLoS One. 2019 May 28;14(5):e0216934. doi: 10.1371/journal.pone.0216934. eCollection 2019.

22.

Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.

Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami SS, Kishan AU, Wang C, Schaeffer EM, Roach M 3rd, Pisansky TM, Shipley WU, Freedland SJ, Sandler HM, Halabi S, Feng FY, Dignam JJ, Nguyen PL, Schipper MJ, Spratt DE.

JAMA Oncol. 2019 Jul 1;5(7):975-983. doi: 10.1001/jamaoncol.2019.0826.

23.

On the use of min-max combination of biomarkers to maximize the partial area under the ROC curve.

Ma H, Halabi S, Liu A.

J Probab Stat. 2019;2019. pii: 8953530. doi: 10.1155/2019/8953530. Epub 2019 Feb 3.

24.

Deep learning to automate Brasfield chest radiographic scoring for cystic fibrosis.

Zucker EJ, Barnes ZA, Lungren MP, Shpanskaya Y, Seekins JM, Halabi SS, Larson DB.

J Cyst Fibros. 2019 May 2. pii: S1569-1993(19)30075-X. doi: 10.1016/j.jcf.2019.04.016. [Epub ahead of print]

PMID:
31056440
25.

Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC).

Ryan CJ, Dutta S, Kelly WK, Russell C, Small EJ, Morris MJ, Taplin ME, Halabi S; From The Alliance for Clinical Trials in Oncology Genitourinary Committee.

Prostate Cancer Prostatic Dis. 2019 May 3. doi: 10.1038/s41391-019-0152-3. [Epub ahead of print]

26.

Effectiveness of digital technologies at improving vaccine uptake and series completion - A systematic review and meta-analysis of randomized controlled trials.

Atkinson KM, Wilson K, Murphy MSQ, El-Halabi S, Kahale LA, Laflamme LL, El-Khatib Z.

Vaccine. 2019 May 21;37(23):3050-3060. doi: 10.1016/j.vaccine.2019.03.063. Epub 2019 Apr 26. Review.

PMID:
31036457
27.

Adhesion durability of dual-cure resin cements and acid-base resistant zone formation on human dentin.

Aung SSMP, Takagaki T, Ko AK, Halabi S, Sato T, Ikeda M, Nikaido T, Burrow MF, Tagami J.

Dent Mater. 2019 Jul;35(7):945-952. doi: 10.1016/j.dental.2019.02.020. Epub 2019 Apr 26.

PMID:
31036261
28.

Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes.

Sugimoto T, Hamasaki T, Evans SR, Halabi S.

Lifetime Data Anal. 2019 Apr 12. doi: 10.1007/s10985-019-09470-4. [Epub ahead of print]

PMID:
30980317
29.

Effect of Office Bleaching on Enamel Bonding Performance.

Halabi S, Matsui N, Nikaido T, Burrow MF, Tagami J.

J Adhes Dent. 2019;21(2):167-177. doi: 10.3290/j.jad.a42362.

PMID:
30949630
30.

Sonographic Diagnosis of Velamentous and Marginal Placental Cord Insertion.

Kelley BP, Klochko CL, Atkinson S, Hillman D, Craig BM, Sandberg SA, Gaba AR, Halabi SS.

Ultrasound Q. 2019 Mar 11. doi: 10.1097/RUQ.0000000000000437. [Epub ahead of print]

PMID:
30870317
31.

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.

Armstrong AJ, Halabi S, Luo J, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Healy P, Anand M, Rothwell CJ, Rasmussen J, Thornburg B, Berry WR, Wilder RS, Lu C, Chen Y, Silberstein JL, Kemeny G, Galletti G, Somarelli JA, Gupta S, Gregory SG, Scher HI, Dittamore R, Tagawa ST, Antonarakis ES, George DJ.

J Clin Oncol. 2019 May 1;37(13):1120-1129. doi: 10.1200/JCO.18.01731. Epub 2019 Mar 13.

PMID:
30865549
32.

Integrating noncommunicable disease services into primary health care, Botswana.

Tapela NM, Tshisimogo G, Shatera BP, Letsatsi V, Gaborone M, Madidimalo T, Ovberedjo M, Jibril HB, Tsima B, Nkomazana O, Dryden-Peterson S, Lockman S, Masupe T, Hirschhorn LR, El Halabi S.

Bull World Health Organ. 2019 Feb 1;97(2):142-153. doi: 10.2471/BLT.18.221424. Epub 2019 Jan 8.

33.

Evidence Synthesis to Accelerate and Improve the Evaluation of Therapies for Metastatic Hormone-sensitive Prostate Cancer.

Tierney JF, Vale CL, Parelukar WR, Rydzewska L, Halabi S.

Eur Urol Focus. 2019 Mar;5(2):137-143. doi: 10.1016/j.euf.2019.01.005. Epub 2019 Feb 1.

PMID:
30713089
34.

Rationale and Design of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Mangat PK, Halabi S, Bruinooge SS, Garrett-Mayer E, Alva A, Janeway KA, Stella PJ, Voest E, Yost KJ, Perlmutter J, Pinto N, Kim ES, Schilsky RL.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00122. Epub 2018 Jul 11.

35.

Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel.

Halabi S, Dutta S, Tangen CM, Rosenthal M, Petrylak DP, Thompson IM Jr, Chi KN, Araujo JC, Logothetis C, Quinn DI, Fizazi K, Morris MJ, Eisenberger MA, George DJ, De Bono JS, Higano CS, Tannock IF, Small EJ, Kelly WK.

J Clin Oncol. 2019 Feb 10;37(5):403-410. doi: 10.1200/JCO.18.01279. Epub 2018 Dec 21.

36.

Deep-learning-assisted diagnosis for knee magnetic resonance imaging: Development and retrospective validation of MRNet.

Bien N, Rajpurkar P, Ball RL, Irvin J, Park A, Jones E, Bereket M, Patel BN, Yeom KW, Shpanskaya K, Halabi S, Zucker E, Fanton G, Amanatullah DF, Beaulieu CF, Riley GM, Stewart RJ, Blankenberg FG, Larson DB, Jones RH, Langlotz CP, Ng AY, Lungren MP.

PLoS Med. 2018 Nov 27;15(11):e1002699. doi: 10.1371/journal.pmed.1002699. eCollection 2018 Nov.

37.

The RSNA Pediatric Bone Age Machine Learning Challenge.

Halabi SS, Prevedello LM, Kalpathy-Cramer J, Mamonov AB, Bilbily A, Cicero M, Pan I, Pereira LA, Sousa RT, Abdala N, Kitamura FC, Thodberg HH, Chen L, Shih G, Andriole K, Kohli MD, Erickson BJ, Flanders AE.

Radiology. 2019 Feb;290(2):498-503. doi: 10.1148/radiol.2018180736. Epub 2018 Nov 27.

PMID:
30480490
38.

Deep learning for chest radiograph diagnosis: A retrospective comparison of the CheXNeXt algorithm to practicing radiologists.

Rajpurkar P, Irvin J, Ball RL, Zhu K, Yang B, Mehta H, Duan T, Ding D, Bagul A, Langlotz CP, Patel BN, Yeom KW, Shpanskaya K, Blankenberg FG, Seekins J, Amrhein TJ, Mong DA, Halabi SS, Zucker EJ, Ng AY, Lungren MP.

PLoS Med. 2018 Nov 20;15(11):e1002686. doi: 10.1371/journal.pmed.1002686. eCollection 2018 Nov.

39.

Combined Performance of Screening and Variable Selection Methods in Ultra-High Dimensional Data in Predicting Time-To-Event Outcomes.

Pi L, Halabi S.

Diagn Progn Res. 2018;2. pii: 21. doi: 10.1186/s41512-018-0043-4. Epub 2018 Sep 26.

40.

Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series.

Mohler JL, Halabi S, Ryan ST, Al-Daghmin A, Sokoloff MH, Steinberg GD, Sanford BL, Eastham JA, Walther PJ, Morris MJ, Small EJ.

Prostate Cancer Prostatic Dis. 2019 May;22(2):309-316. doi: 10.1038/s41391-018-0106-1. Epub 2018 Nov 1.

41.

Migrating to the Modern PACS: Challenges and Opportunities.

Berkowitz SJ, Wei JL, Halabi S.

Radiographics. 2018 Oct;38(6):1761-1772. doi: 10.1148/rg.2018180161. Review.

PMID:
30303805
42.

Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update' [Eur J Cancer 94 (May 2018) 115-125].

Choueiri TK, Hessel C, Halabi S, Sanford B, Michaelson MD, Hahn O, Walsh M, Olencki T, Picus J, Small EJ, Dakhil S, Feldman DR, Mangeshkar M, Scheffold C, George D, Morris MJ.

Eur J Cancer. 2018 Nov;103:287. doi: 10.1016/j.ejca.2018.09.022. Epub 2018 Sep 27. No abstract available.

43.

Power matters: The role of power and morality needs in competitive victimhood among advantaged and disadvantaged groups.

Kahalon R, Shnabel N, Halabi S, SimanTov-Nachlieli I.

Br J Soc Psychol. 2018 Aug 29. doi: 10.1111/bjso.12276. [Epub ahead of print]

PMID:
30156303
44.

Off-Label Marketing's Audiences: The 21st Century Cures Act and the Relaxation of Standards for Evidence-Based Therapeutic and Cost-Comparative Claims.

Halabi SF.

Am J Law Med. 2018 May;44(2-3):181-196. doi: 10.1177/0098858818789420. No abstract available.

PMID:
30106659
45.

Improving Door-to-Balloon Time of Patients with ST-Segment Elevation Myocardial Infarction (STEMI) in the Emergency Department.

Halabi S, Elias A, Goldberg M, Hurani H, Darawsha H, Shachar S, Ashkenazi M.

Isr Med Assoc J. 2018 Aug;20(8):476-479.

46.

The association between cardiovascular disease gene mutations and recurrent pregnancy loss in the Lebanese population.

El Achi H, Awwad J, Abou Daya S, Halabi S, Damianos S, Mahfouz R.

Mol Biol Rep. 2018 Oct;45(5):911-916. doi: 10.1007/s11033-018-4237-1. Epub 2018 Jul 4.

PMID:
29974397
47.

Future time perspective and interpersonal empathy: Implications for preferring autonomy- versus dependency-oriented helping.

Chernyak-Hai L, Halabi S.

Br J Soc Psychol. 2018 Oct;57(4):793-814. doi: 10.1111/bjso.12260. Epub 2018 Jun 21.

PMID:
29926924
48.

Health Data and Privacy in the Digital Era.

Gostin LO, Halabi SF, Wilson K.

JAMA. 2018 Jul 17;320(3):233-234. doi: 10.1001/jama.2018.8374. No abstract available.

PMID:
29926092
49.

Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance).

Li M, Mulkey F, Jiang C, O'Neil BH, Schneider BP, Shen F, Friedman PN, Momozawa Y, Kubo M, Niedzwiecki D, Hochster HS, Lenz HJ, Atkins JN, Rugo HS, Halabi S, Kelly WK, McLeod HL, Innocenti F, Ratain MJ, Venook AP, Owzar K, Kroetz DL.

Clin Cancer Res. 2018 Oct 1;24(19):4734-4744. doi: 10.1158/1078-0432.CCR-17-1523. Epub 2018 Jun 5.

50.

Meta-Analysis of Studies Comparing Dual- Versus Mono-Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation.

Al Halabi S, Newman J, Farkouh ME, Fortuin D, Leya F, Sweeney J, Darki A, Lopez J, Steen L, Lewis B, Webb J, Leon MB, Mathew V.

Am J Cardiol. 2018 Jul 1;122(1):141-148. doi: 10.1016/j.amjcard.2018.03.019. Epub 2018 Mar 28. Review.

PMID:
29779587

Supplemental Content

Loading ...
Support Center